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Abstract
Nutrition during pregnancy and lactation could exert a key role not only on maternal bone,
but also could influence the skeletal development of the offspring. This study was performed
in rats to assess the relationship between maternal dietary intake of prebiotic oligofructose-
enriched inulin and its role in bone turnover during gestation and lactation, as well as its
effect on offspring peak bone mass/architecture during early adulthood. Rat dams were fed
either with standard rodent diet (CC group), calcium-fortified diet (Ca group), or prebiotic oli-
gofructose-enriched inulin supplemented diet (Pre group), during the second half of gesta-
tion and lactation. Bone mineral density (BMD) and content (BMC), as well as micro-
structure of dams and offspring at different stages were analysed. Dams in the Pre group
had significantly higher trabecular thickness (Tb.Th), trabecular bone volume fraction (BV/
TV) and smaller specific bone surface (BS/BV) of the tibia in comparison with CC dams.
The Pre group offspring during early adulthood had an increase of the lumbar vertebra BMD
when compared with offspring of CC and Ca groups. The Pre group offspring also showed
significant increase versus CC in cancellous and cortical structural parameters of the lumbar
vertebra 4 such as Tb.Th, cortical BMD and decreased BS/BV. The results indicate that oli-
gofructose-enriched inulin supplementation can be considered as a plausible nutritional
option for protecting against maternal bone loss during gestation and lactation preventing
bone fragility and for optimizing peak bone mass and architecture of the offspring in order to
increase bone strength.
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Introduction
Osteoporosis has been recognized as an established and well-defined disease that affects mil-
lions of people around the world[1]. It is defined by the National Institute of Health as a skele-
tal disorder characterized by compromised bone strength that increases the risk of fracture[2].
The bone mass of an individual in adult life depends on the peak attained during skeletal
growth and the subsequent rate of bone loss [3, 4]. In this sense, the quantity of bone could be
affected during different periods along individual’s life. Two of the most important periods
could be childhood and adolescence, being the increment of peak bone mass attained during
these periods one of the most important strategies for preventing osteoporosis and associated
fractures later in life. Other important periods that could affect in a significant way the bone
mass and structure are gestation and lactation. During gestation and especially during lactation
a high quantity of Ca is mobilized, mainly from maternal skeleton, to meet the Ca requirements
for foetal and neonatal growth and milk production[5]. In the course of these periods, a rapid
and consistent fall in maternal bone mass is produced in parallel with the increase in the bone
turnover rate [6] Thus, it has been estimated that losses of bone mineral content (BMC) and
bone mineral density (BMD) are between 5% and 14% resulting in the development of a tran-
sient maternal osteopenia that normally is recovered after weaning but, in some rare cases,
could produce backache and vertebrae fractures in the lactating women [7–9].
Gestation and lactation have been also related as principal factors that could have an impact
on bone accrual of the offspring during the growing stages of life, leading to an adequate peak
bone mass. In recent years, environmental factors during intrauterine life, such as maternal
nutrition, have been identified to influence the growth and development of children [10]. The
relatively rapid rate of mineral gain during intrauterine and early postnatal life, coupled with
the plasticity of skeletal development in the uterus, offer the possibility of profound interac-
tions between the genome and the environment at this stage of life [11, 12]. This phenomenon
termed as ‘programming’ was defined as “persisting changes in structure and function caused
by adverse environmental influences at a critical stage of early development” [13]. Thus, mater-
nal intake of nutrients such as proteins, fats, minerals (Ca, P, Mg, K), and vitamins (folate and
vitamin D) during pregnancy has been shown to predict height, BMC, bone area, and areal
bone mineral density in prepubertal children [14–17].
Ca is the most widely evaluated nutrient in prospective and interventional human studies
with the aim of establishing the relationship between maternal dietary status, maternal bone
health and offspring skeletal development[18, 19]. The National Academy of Sciences recom-
mends for women who are pregnant or breastfeeding to consume 1,000 mg of Ca each day. In
fact, different studies have shown that increased Ca intake during gestation and lactation can
preserve maternal bone and can also promote a higher peak bone mass in the offspring [10, 16,
20]. However, other studies have not shown this positive correlation between both variables
[21], leading to consider other alternative technologies by the scientific community.
Alternative, other nutrients and functional foods are being studied for their programming
abilities. One of the candidates, on which it is gaining knowledge in this area, is prebiotics. A
prebiotic is a non-digestible food ingredient that benefits the host by selectively stimulating the
growth and/or activity of probiotic bacteria/s in the colon that could deliver potential benefits
for the host health[22]. In fact, beneficial effects of prebiotic fibres are been observed on immu-
nological, metabolic and gastrointestinal systems [23, 24].
Among the most studied prebiotics are those derived from chicory: inulin and oligofructose
(FOS). Both prebiotics are natural constituents of vegetables, fruits and cereals and have been
recognised as dietary fibres in most countries[25]. FOS and inulin have been associated with
increases of calcium absorption in rodents[26] and in humans[27] and also with a clear
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beneficial effect on bone metabolism in adolescent [28, 29] and postmenopausal model[30].
Thus, long-term prebiotic supplementation in growing rats has shown to increase not only the
accumulation of bone mineral but also to improve the trabecular structure of the bone[31, 32]
even when rats were fed with a low calcium diet (0.2%)[33]. Similarly, prebiotics supplementa-
tion of the diet prevent trabecular bone loss in different animal models of osteoporosis using
ovariectomized rats[34] and mice[35]. In humans, prebiotics consumption has been related
with higher calcium absorption in the adolescence if fed short-term[36, 37] that have a signifi-
cant higher impact on bone mineral content of young population if fed during a long-term
period[28]. These results could indicate that prebiotic consumption during pubertal growth
enhances bone mineralization that could result in an increase in the peak bone mass during
adolescence[38]. Although there are promising data of the effect of the prebiotic supplementa-
tion in humans and animals, no studies were found describing the programming effects of pre-
biotics on maternal and offspring bones.
The aim of our study was to determine in rats the effects of maternal diet supplementation
with prebiotic oligofructose-enriched inulin during gestation and lactation, on the prevention
of maternal bone loss at weaning and on the offspring peak bone mass and architecture accre-
tion. In the present study we assessed the possible effects of prebiotic oligofructose-enriched
inulin on the density and microstructure of axial and appendicular bones as well as bone bio-
markers to assess biological status of the rats.
Material and Methods
Animals and experimental design
This study was carried out in strict accordance with the recommendations in the ethical guide-
lines for animal experimentation provided by the Spanish National Research Council (RD
1201/2005 October 10). The protocol was approved by the Committee on the Ethics of Animal
Experiments of the Unidad de Experimentación Animal-Estación Experimental del Zaidín
(CSIC, Granada, Spain) (Permit Number: CEEA-INAN-2008-004). All interventions were per-
formed under sodium pentobarbital anesthesia, and all efforts were made to minimize
suffering.
Thirty pregnant Sprague-Dawley rats, 15wks old, at 11th gestation day were obtained from
Charles Rivers Laboratories (Orleans Cedex, France). The dam rats were housed under stan-
dardized environmental conditions (22°C, relative humidity of 50%, on a 12 h light/dark
cycle). They were randomly divided into three groups according to the feeding pattern (n = 10/
group): the Control group (CC group), which received purified rodent diet, AIN93-G [39]; the
Ca-fortified group (Ca group), which received AIN93-G diet fortified with 0.5% calcium car-
bonate (CaCO3) i.e., 1 g Ca
2+/100 g of diet, and the prebiotic oligofructose-enriched inulin
group (Pre group), which received AIN93-G diet containing 7.5% of the total carbohydrates as
prebiotic oligofructose-enriched inulin (Synergy-11, Orafti, Belgium). This prebiotic was a 1:1
mixture of fructooligosacharides, with an average degree of polymerization (DP) of 4, and high
performance inulin with an average DP of 25.
All the rats were fed ad libitum and were given free access to de-ionized water during the
entire period of pregnancy and lactation (Fig 1)
The compositions of experimental diets are defined in Table 1.
During these periods, control of dams’ weight and food intake was performed twice a week.
After delivery, to standardize and minimize variation in the pups nutrition during suckling, lit-
ters from the same group were mixed, and 8 pups (5 females and 3 males) were randomly
housed to each dam. Male pups were introduced to generate a litter as similar as possible to
natural, avoiding any gender effect during the suckling, but were not subsequently used in the
Mother’s Prebiotic Intake and Maternal and Offspring Bone
PLOSONE | DOI:10.1371/journal.pone.0154120 April 26, 2016 3 / 22
study. During their suckling period, the offspring received only the dam’s milk as source of
feeding.
At weaning, female pups were separated from the dams and housed in groups of 4 per cage.
Each animal received a controlled AIN93-G diet. Forty three days after delivery, the rats were
individualized and fed with an AIN93-M maintenance purified diet [39, 40] until the end of
their adolescence period (90 days).
Pup body weights were measured twice a week during the lactating period and weekly from
weaning until the end of the adolescence for the offspring.
Before the sacrifices at the end of the weaning period for dams and of the adolescence, in
the case of the offspring, urine was collected for 12 h in acidified tubes to measure biomarkers
of bone resorption.
Sacrifices of dams and pups were carried out under fasting condition at the end of delivery
(pups), their weaning period (23 days) (pups and dams), and at the end of their adolescence
(90 days, pups). They were anesthetized via intraperitoneal with pentobarbital sodium, 30mg/
kg of body weight (Abbott Laboratories, North Chicago, IL) and blood was sampled by cardiac
puncture. Serum was isolated after centrifugation at 1,500 × g for 10 min at 4°C, frozen, and
stored at -80°C until further analysis of bone biomarkers. Dams’ caecal content were collected,
frozen and stored at -80°C for posterior analysis of pH. Femurs, tibiae and vertebrae, were also
isolated and kept at -20°C until their analysis.
Fig 1. Experimental design.CC, Control group; Ca, Calcium-fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group. Sacrifices
were carried out at the end of each period, delivery, pups; weaning, pups and dams; adolescence, pups. *Prebiotic oligofructose-enriched inulin source
provided by Orafti is a 1/1 mixture of oligofructose and high performance inulin.
doi:10.1371/journal.pone.0154120.g001
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Biochemical analyses
Serum osteocalcin was measured by a specific competitive enzyme-linked immunosorbent
assay (ELISA) (Rat-MIDTM Osteocalcin EIA, IDS Inc., USA) and Alkaline phosphatase (AP)
was measured by an automated colorimetric assay (Alcyon 300 analyzer; Abbott Laboratories,
USA) using p-nitrophenyl phosphate as the substrate according to the International Federation
of Clinical Chemistry and Laboratory Medicine[41]. Parathyroid hormone (PTH) was mea-
sured by a two-site ELISA (Rat intact PTH ELISA, ALPCO diagnostics, USA).
Biomarkers of bone resorption deoxypyridinoline (DPD) and pyridinoline (PYD) were
measured in 12h-acidified urine, by using a competitive ELISAs (Metra tDPD and Microvue
PYD, Quidel Corporation, USA). In order to normalize this parameter, urinary creatinine con-
centration was determined by the Jaffé method [42] using a clinical chemistry analyzer (Alcyon
300 analyzer, Abbott Laboratories, USA).
For the measure of the pH of caecal content, 0.5 g of the content was homogenized with 10
ml of deionized water (Milli-Q) and measured using a laboratory pHmeter (CRISON, Barce-
lona, Spain).
Ex-vivo densitometry analysis
The whole BMD and BMC of total body at weaning and of isolated bones (femurs, tibiae and
vertebrae) of dams and adolescent rats were measured by using peripheral dual-energy X-ray
absorptiometry using a pDEXA1 densitometer (Norland Corp., Fort Atkinson, WI, USA). The
femurs were measured from the femoral neck to the knee joint. The tibiae, including the fibula,
were measured from the knee to the ankle joint and the vertebrae were measured from the
Table 1. Composition of the experimental diets used in the study.
AIN93-G (CC group) AIN93-G+Ca (Ca group) AIN93-G+Pre (Pre group)
Total Fat (g/kg diet) 71.8 71.8 71.8
Soy oil 71.8 71.8 71.8
Protein (g/kg diet) 183.1 183.1 183.1
Carbohydrate (g/kg diet) 661.6 661.6 661.6
Cellulose 49.5 49.5 0.0
Prebiotic Oligofructose-enriched inulin* 0.0 0.0 75.0
Minerals (/kg diet)
Calcium (g) 5.25 10.5 5.25
Magnesium (mg) 539.0 539.0 539.0
Manganesium (mg) 15.0 15.0 15.0
Phosphorous (g) 3.15 3.15 3.15
Zinc (mg) 39.9 39.9 39.9
Vitamins (/kg diet)
Vitamin A (IU) 4200 4200 4200
Vitamin D3 (IU) 1200 1200 1200
Vitamin E (IU) 90 90 90
Vitamin K1 (mg) 1.08 1.08 1.08
Energy (kcal/kg diet) 3880.0 3880.0 3840.0
CC, Control group; Ca, Calcium-fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group.
*Prebiotic oligofructose-enriched inulin source provided by Orafti is a 1/1 mixture of oligofructose and high performance inulin.
doi:10.1371/journal.pone.0154120.t001
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inferior level of the lumbar vertebra 3 to the superior level of the lumbar vertebra 5 (LV3-LV5).
In the current study, all measurements were performed by the same technician.
Micro-CT analysis
Femurs, tibiae and/or vertebrae (LV4) were scanned ex-vivo at delivery (pups, femur and LV4),
weaning (dams, femur, tibia and LV4, and pups, femur and LV4) and adolescence (pups, LV4)
with high-resolution μCT using a Metris (XTek) Benchtop 160Xi CT scanner (University of
Southampton) and a VivaCT-40 system (Scanco Medical AG, Brüttisellen, Switzerland). The
femur and the tibia secondary spongiosa were scanned within the metaphysis below the growth
plate. The LV4 spongiosa was scanned between the two growth plates. All scans from birth and
weaning of the offspring bones were taken at 150kV, 60μA, using a molybdenum target. Sam-
ples at those ages were scanned at 19μm resolution with an exposure time of 534ms and 4x dig-
ital gain. Images in three-dimensional (3D) volume were reconstructed from the individual tiff
images obtained from the CT scanner using the Metris (XTek) CT-Pro software. Cortical from
LV4 at the end of adolescence was scanned at 70kV and 114μA, with a resolution of 20μm and
an integration time of 800ms for the vertebrae samples. To obtain the 3D image of the LV4, a
threshold 240 was used to binarize the cortex in this analysis. Threshold was adjusted in order
to obtain the best 3D reconstructions.
Trabecular architecture parameters including trabecular number (Tb.N, measure of the
average number of trabeculae per unit length, which is related with trabeculae density, in 1/
mm), trabecular thickness (Tb.Th, the thickness of the trabeculae in mm), trabecular separa-
tion (Tb.Sp, the distance between trabeculae in mm), bone volume fraction (BV/TV, the ratio
of spongy bone tissue including mineralized bone and osteoid), specific bone surface (BS/BV,
to characterize the thickness and complexity of structures, in mm-1) and connectivity density
(Conn.D, a measure of the degree of connectivity of trabeculae normalized by TV, in mm-3)
were determined. Cortical parameters including volumetric BMD of the cortical bone (C.
BMD), cortical thickness (C.Th, mean thickness of the cortical shell, in mm), and cortical
porosity (C.Sp, defined as the volume of pores divided by the volume of cortical bone, in %)
and the polar moment of inertia (pMOI, in mm4), as a structural index of resistance to torsion
were also determined.
Statistical analysis
Results were expressed as mean ± standard error of mean (SEM).
To evaluate differences attributable to the diet in the different markers, we performed a one-
way ANOVA, followed by post hoc analysis with Fisher’s protected least significant difference
mean separation test [43]. In groups which failed to exhibit normal distributions or equal vari-
ance, Kruskal-Wallis tests were performed. A value of p<0.05 was considered significant while
a p-value between 0.05 and 0.10 was also noted as a trend. Statgraphics Centurion XVI (Stat
Point Inc., Herndon, Virginia, USA) software has been used for data treatment and statistical
analysis.
Results
Effect of maternal diets on dams’ and offspring weight
Dams’ weight evolution and food intake were similar between the CC and experimental groups
during both gestation and lactation periods (Fig 2). At sacrifice no differences were found in
dams’ weight (CC group: 258.0 ± 5.9g; Ca group: 265.0 ± 4.2g and Pre group: 251.4 ± 5.7g).
Mother’s Prebiotic Intake and Maternal and Offspring Bone
PLOSONE | DOI:10.1371/journal.pone.0154120 April 26, 2016 6 / 22
Pups’ weight evolution was showed in Fig 3. Although nutrition intervention during gesta-
tion and lactation did not affect maternal body weight, the offspring body weight was signifi-
cantly affected. At birth, the average weight of the offspring was significantly lower (p = 0.011)
in the Ca group (8.24 ± 0.10g) compared to the average weight of the CC group (8.65 ± 0.12g).
In contrast, no differences were found in pups weight between the Control and Pre groups
(8.52 ± 0.13g).
At weaning, the pups from the Ca group mothers showed a significantly lower (p<0.05)
body weight (62.0 ± 0.9g) compared to the CC group (72.2 ± 1.3g) and Pre group (67.6 ± 1.0g).
At the end of adolescence, offspring body weights were not different among the study
groups (CC group: 272.7± 9.0g; Ca group: 250.0± 8.6g; Pre group: 257.7± 7.1g).
Effect of maternal diets on dams’ bone health
Densitometry results. In absolute terms the femoral, the tibia and the vertebrae BMD and
BMC were lower in dams which received the Ca-fortified diet with respect to the CC group,
while these parameters were almost similar or even higher than control in dams fed with the
diet supplemented with prebiotic oligofructose-enriched inulin (Table 2). Significant differ-
ences were only found on the tibia where CC and Pre groups showed a higher BMD (CC vs Ca,
Fig 2. Maternal body weight evolution.Mean values with their standard deviations. (—)CC Group, Control group; (- - -) Ca Group, Calcium-fortified group;
() Pre Group, Prebiotic oligofructose-enriched inulin supplemented group. GD, Gestational day; LD, Lactation day.
doi:10.1371/journal.pone.0154120.g002
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p = 0.049; Ca vs Pre, p = 0.009) and BMC (CC vs Ca, p = 0.029; Ca vs Pre, p = 0.026) with
respect to Ca group.
Micro-structure results. Micro-structure analysis of bones using micro CT technology
pointed out the same pattern shown in pDEXA analysis. In general, and for all the bones
Fig 3. Pups body weight gain.Mean values with their standard deviations. (—)CC Group, Control group;
(- - ) Ca Group, Calcium-fortified group; () Pre Group, Prebiotic oligofructose-enriched inulin supplemented
group. Significant differences (p<0.05) * CC group vs Ca group; # Ca group vs Pre group.
doi:10.1371/journal.pone.0154120.g003
Table 2. pDEXA analysis of bonemineral content (BMC) and density (BMD), from dams at sacrifice (end of lactation).
CC group Ca group Pre group
(n = 10) (n = 10) (n = 10)
Femur
BMC (g) 0.3075 ± 0.0114 0.2813 ± 0.0128 0.3127 ± 0.0146
BMD (g/cm2) 0.1532 ± 0.0038 0.1419 ± 0.0044 0.1585 ± 0.0057
Tibia
BMC (g) 0.2394 ± 0.0062 0.2122 ± 0.0094CC 0.2407 ± 0.0096Ca
BMD (g/cm2) 0.1229 ± 0.0019 0.1161 ± 0.0019CC 0.1258 ± 0.0032Ca
LV3-5
BMC (g) 0.3064 ± 0.0106 0.2815 ± 0.0180 0.3138 ± 0.0165
BMD (g/cm2) 0.1473 ± 0.0029 0.1373 ± 0.0048 0.1500 ± 0.0039
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium-fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group.
Statistical significance was defined as p<0.05.
CC significantly different vs the CC group
Ca significantly different vs the Ca group.
doi:10.1371/journal.pone.0154120.t002
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Table 3. Trabecular architecture of dams bones at sacrifice (end of lactation).
CC group Ca group Pre group
(n = 8) (n = 8) (n = 8)
Femur
BV/TV 0.1584 ± 0.0116 0.1291 ± 0.0086 0.1521 ± 0.0154
BS/BV (1/mm) 34.29 ± 1.27 33.77 ± 0.62 32.59 ± 1.45
Tb. Th (mm) 0.0736 ± 0.0023 0.0715 ± 0.0018 0.0744 ± 0.0020
Tb. Sp (mm) 0.6185 ± 0.0482 0.7150 ± 0.050 0.6169 ± 0.0767
Tb. N (1/mm) 1.816 ± 0.1389 1.535 ± 0.0985 1.516 ± 0.077
Conn.D 70.01 ± 3.14 57.85 ± 4.25 73.97 ± 11.47
Tibia
BV/TV 0.1274 ± 0.0094 0.1211 ± 0.0065 0.1723 ± 0.0213CC,Ca
BS/BV (1/mm) 43.55 ± 1.13 41.30 ± 0.85 38.33 ± 1.31CC
Tb. Th (mm) 0.0614 ± 0.0014 0.0631 ± 0.0011 0.0669 ±0.0017CC
Tb. Sp (mm) 0.4036 ± 0.0300 0.4956 ± 0.0364 0.3795 ± 0.0472
Tb. N (1/mm) 2.598 ± 0.1933 2.151 ± 0.1371 2.979 ± 0.3915
Conn.D 73.78 ± 4.57 66.18 ± 4.71 100.1 ± 14.58CC,Ca
Vertebra (LV4)
BV/TV 0.2759 ± 0.0127 0.2580 ± 0.0143 0.2985 ± 0.0234
BS/BV (1/mm) 30.27 ± 1.01 31.83 ± 1.11 28.92 ± 1.18
Tb. Th (mm) 0.0750 ± 0.0018 0.0713 ± 0.0016 0.0768 ± 0.0019
Tb. Sp (mm) 0.2544 ± 0.0063 0.2571 ± 0.0095 0.2419 ± 0.0119
Tb. N (1/mm) 3.978 ± 0.081 3.947 ± 0.124 4.140 ± 0.179
Conn.D 104.0 ± 4.1 104.6 ± 3.6 99.1 ± 4.5
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
BV/TV, Bone volume/total volume ratio; BS/BV, Bone surface/bone volume; Tb.Th, Trabecular Thickness; Tb.Sp, Trabecular Separation; Tb.N, Trabecular
Number; Conn.D, Connectivity Density, LV4, lumbar vertebra 4. Statistical significance was defined as p < 0.05
CC significantly different vs the CC group
Casignificantly different vs the Ca group.
doi:10.1371/journal.pone.0154120.t003
Fig 4. Representative micro CT images of trabecular bone in the tibia of dams. CC, Control group; Ca, Calcium-fortified group; Pre, Prebiotic
oligofructose-enriched inulin supplemented group.
doi:10.1371/journal.pone.0154120.g004
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analysed, the Pre group showed better trabecular micro-structure than the CC or the Ca groups
(Table 3), being the tibia the most affected by maternal nutrition intervention (Fig 4). Thus, the
tibia of dams in the Pre group showed a significant increase on trabecular thickness (p = 0.014)
and a decrease in BS/BV ratio (p = 0.003) with respect to the CC group, that only reached a
trend when comparing with Ca group (p = 0.073). This group also showed an increase of bone
volume fraction and connectivity density with respect to CC (p = 0.033) and Ca groups
(p = 0.017). Although no statistical differences were reached, it is also remarkable the higher
trabecular number showed in dams from the Pre group (+15%) as compared to the CC group
and +38% vs the Ca group and the lower trabecular space -6% vs the CC group and -23% vs the
Ca group.
Serum bio-markers. In general, no differences were found on serum biomarkers among
the groups. Dams from the Ca group presented in the serum the higher concentration of mark-
ers associated to bone formation (osteocalcin and alkaline phosphatase) and of markers of
bone resorption (DPD and PYD) (Table 4). Serum level of osteocalcin in the Ca group was sta-
tistically different with respect to the CC group (p = 0.007) but not respecting to the Pre group.
Also the Pre group showed an increment with respect to the CC group for this parameter
(p = 0.073).
Caecal content pH. The pH of the caecal content from dams in the Pre group
(8.083 ± 0.208) was significantly decreased respected to the CC group (8.872 ± 0.080;
p = 0.001) and Ca group (8.558 ± 0.127; p = 0.035)
Effect of maternal diets on offspring’s bone health and biomarkers
Results of offspring at delivery. At birth, densitometry analysis was not performed since
the degree of bone mineralization of the new-born rat was not high enough and being below
the detection limit of the densitometer. However, micro CT of trabecular parameters in femurs
and the vertebrae were analysed based on the high sensitivity of this technique as compared to
DEXA.
Pups frommothers in the Ca group (p = 0.004) and Pre group (p = 0.070) had lower femoral
length in comparison to the CC group. Trabecular thickness was also lower in the Ca group
(p = 0.001) and in the Pre group (p = 0.044) compared with CC group. On the other hand,
pups in the Ca group presented a significant higher trabecular number (p = 0.000, vs CC and
Pre) and BS/BV (p = 0.003, vs CC; p = 0.040 vs Pre) than those from mothers in the CC group
Table 4. Bone biomarkers in serum and 12h-urine from the dams at sacrifice (end of lactation).
CC group Ca group Pre group
(n = 10) (n = 10) (n = 10)
Bone formation biomarkers
Osteocalcin (mg/mol creatinine) 7489 ± 759.4 11133 ± 1008 CC 9763 ± 869.6
Alkaline phosphatase (U/mmol creatinine) 3874 ± 726.3 5045 ± 639.8 3242 ± 380.3
Bone resorption biomarkers
PTH (mg/mol creatinine) 1030 ± 113.0 880.5 ± 120.3 828.0 ± 90.74
DPD (μmol/mol creatinine) 166.3± 13.03 219.4 ± 26.59 187.5 ± 20.22
PYD (μmol/mol creatinine) 214.4 ± 11.46 242.4 ± 26.30 213.1 ±19.87
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
Osteocalcin, Alkaline phosphatase and PTH (Parathyroid hormone) were measure in serum. DPD (Deoxypyridinoline) and PYD (Pyridinoline) were
measured in 12h-acidified urine. Statistical significance was defined as p < 0.05.
CC significantly different vs the CC group.
doi:10.1371/journal.pone.0154120.t004
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and the Pre group (Table 5). Regarding trabecular structure of lumbar vertebrae, there was a
positive increase in the trabecular number for both the Ca and Pre groups with respect to the
CC group (+13% for the Ca group and +10% for the Pre group), although is this group which
showed a higher trabecular thickness with respect to the other two groups (p = 0.019, vs CC;
p = 0.045 vs Pre).
Results of offspring at weaning. No differences were found at this period in the whole
body BMD and BMC of the female offspring (data not shown). However, in general terms,
maternal nutritional intervention induced an improvement in the trabecular architecture of
the vertebrae in the female offspring at weaning period. Although no significance was achieved,
trabecular separation for the Ca group and the Pre group showed a decrease around -35% and
-30% with respect to the CC group. In similar terms, a small increase with respect to the CC
group was observed in the offspring from the Ca and Pre groups for BV/TV, by 7% and 5%
respectively, and for trabecular thickness, by 11% for the Ca group and 7% for the Pre group. A
significant decrease was found on BS/BV ratio (p = 0.033, vs CC; p = 0.012 vs Pre) and length
(p = 0.002, vs CC; p = 0.005 vs Pre) in the Ca group vs both other groups (Table 6).
Results of offspring at adolescence. At the end of adolescence, pDEXA examination of
appendicular bones, femur and tibia, did not differ among the nutritional intervention groups.
In contrast, the lumbar vertebrae BMD of the Pre group is increased significantly compared to
the CC (p = 0.039) and the Ca (p = 0.001) groups (Table 7), also BMC of this bone were influ-
enced by maternal nutritional intervention, increasing in the Pre group more than 7% with
respect to CC group and 16% with respect to Ca group. It is also remarkable the decrease of 8%
that was found in the BMD of the Ca group with respect to CC group (p = 0.075). Based on
Table 5. Trabecular architecture of offspring bones at delivery period.
CC group Ca group Pre group
(n = 8) (n = 8) (n = 8)
Femur
Length (mm) 4.283 ± 0.076 3.971 ± 0.058CC 4.099 ± 0.069
BV/TV 0.476 ± 0.030 0.468 ± 0.012 0.445 ± 0.033
BS/BV (1/mm) 19.47 ± 1.09 23.90 ± 1.23CC 22.41 ± 1.151Ca
Tb. Th (mm) 0.105 ± 0.006 0.079 ± 0.003CC 0.091 ± 0.005CC
Tb. Sp (mm) 0.117 ± 0.009 0.091 ± 0.004 0.118 ± 0.012
Tb. N (1/mm) 4.53 ± 0.13 5.89 ± 0.15CC 4.87 ± 0.22Ca
Vertebra (LV4)
Length (mm) 0.739 ± 0.016 0.756 ± 0.020 0.693 ± 0.023
BV/TV 0.742 ± 0.029 0.671 ± 0.038 0.676 ± 0.034
BS/BV (1/mm) 17.39 ± 1.55 18.81 ± 0.71 21.12 ± 1.38
Tb. Th (mm) 0.122 ± 0.012 0.093 ± 0.003CC 0.098 ± 0.006CC
Tb. Sp (mm) 0.041 ± 0.005 0.040 ± 0.004 0.047 ± 0.005
Tb. N (1/mm) 6.35 ± 0.46 7.20 ± 0.37 6.97 ± 0.27
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
BV/TV, Bone volume/total volume ratio; BS/BV, Bone surface/bone volume; Tb.Th, Trabecular Thickness; Tb.Sp, Trabecular Separation; Tb.N, Trabecular
Number; LV4, lumbar vertebra 4. Statistical significance was defined as p < 0.05.
CC significantly different vs the CC group
Casignificantly different vs the Ca group.
doi:10.1371/journal.pone.0154120.t005
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those main differences on BMD and BMC of the lumbar vertebra, micro CT analysis was per-
formed only in this bone at this period (Table 8).
The intervention on the mother, during gestation and lactation periods, with the Ca fortified
or prebiotic oligofructose-enriched inulin supplemented diet produced a positive effect on the
trabecular architecture of the vertebrae in their female offspring (Fig 5). BV/TV was
Table 6. Trabecular architecture of offspring bones at weaning period.
CC group Ca group Pre group
(n = 8) (n = 8) (n = 8)
Femur
Length (mm) 19.44 ± 0.09 18.45 ± 0.28CC 18.81 ± 0.24
BV/TV 0.717 ± 0.033 0.657 ± 0.043 0.704 ± 0.008
BS/BV (1/mm) 6.548 ± 0.506 7.812 ± 0.929 7.467 ± 0.239
Tb. Th (mm) 0.312 ± 0.023 0.295 ± 0.020 0.269 ± 0.009
Tb. Sp (mm) 0.122 ± 0.012 0.154 ± 0.021 0.126 ± 0.011
Tb. N (1/mm) 2.318 ± 0.098 2.235 ± 0.071 2.539 ± 0.064Ca
Vertebra (LV4)
Length (mm) 3.260 ± 0.098 2.737 ± 0.118CC 3.191 ± 0.048Ca
BV/TV 0.714 ± 0.038 0.764 ± 0.035 0.747 ± 0.038
BS/BV (1/mm) 8.068 ± 1.053 5.778 ± 0.267CC 8.418 ± 0.584Ca
Tb. Th (mm) 0.227 ± 0.042 0.252 ± 0.030 0.242 ± 0.016
Tb. Sp (mm) 0.112 ± 0.013 0.073 ± 0.006 0.081 ± 0.011
Tb. N (1/mm) 3.051 ± 0.288 3.150 ± 0.246 3.027 ± 0.052
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
BV/TV, Bone volume/total volume ratio; BS/BV, Bone surface/bone volume; Tb.Th, Trabecular Thickness; Tb.Sp, Trabecular Separation; Tb.N, Trabecular
Number; LV4, lumbar vertebra 4. Statistical significance was defined as p < 0.05
CC significantly different vs the CC group
Casignificantly different vs the Ca group.
doi:10.1371/journal.pone.0154120.t006
Table 7. pDEXA analysis of the femur bonemineral content (BMC) and density (BMD) from offspring at adolescence.
CC group Ca group Pre group
(n = 8) (n = 8) (n = 8)
Femur
BMC (g) 0.3643 ± 0.0090 0.3557 ± 0.0095 0.3580 ± 0.0164
BMD (g/cm2) 0.1782 ± 0.0033 0.1741 ± 0.0036 0.1787 ± 0.0042
Tibia
BMC (g) 0.2770 ± 0.0079 0.2752 ± 0.0080 0.2697 ± 0.0106
BMD (g/cm2) 0.1376 ± 0.0026 0.1353 ± 0.0025 0.1368 ± 0.0027
LV4-5
BMC (g) 0.3228 ± 0.0093 0.2982 ± 0.0144 0.3457 ± 0.0175
BMD (g/cm2) 0.1807 ± 0.0047 0.1670 ± 0.0043 0.1974 ± 0.0069CC Ca
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
Statistical significance was defined as p < 0.05
CC significantly different vs the CC group
Casignificantly different vs the Ca group.
doi:10.1371/journal.pone.0154120.t007
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significantly enhanced in the Ca group (22%) (p = 0.007) and also in the Pre group (11%),
although no significant, in comparison to the CC group. Similar results were observed in tra-
becular thickness with an increase of 17% in the Ca group (p = 0.010) and 13% in the Pre
group (p = 0.043) and in BS/BV ratio with a significant decrease of 17% (p = 0.001) and 10%
(p = 0.021) respectively when compared with the CC group. The Ca group also showed a non-
significant but higher decrease in the trabecular separation compared with the CC group
(Table 8).
Cortical parameters of the vertebras of female offspring were also positively affected by the
maternal nutritional intervention during the gestational and lactating periods (Table 8). The
Table 8. Trabecular and cortical architecture lumbar vertebra 4 from offspring at adolescence.
CC group Ca group Pre group
(n = 8) (n = 8) (n = 8)
Trabecular Parameters
BV/TV 0.306 ± 0.007 0.373 ± 0.021CC 0.340 ± 0.017
BS/BV (1/mm) 28.370 ± 0.460 23.640 ± 0.723CC 25.440 ± 1.160CC
Tb. Th (mm) 0.071 ±0.001 0.082 ± 0.004CC 0.080 ± 0.003CC
Tb. Sp (mm) 0.161 ± 0.005 0.139 ± 0.007 0.156 ± 0.007
Tb. N (1/mm) 4.331 ± 0.103 4.524 ± 0.095 4.257 ± 0.115
Cortical Parameters
C.BMD (mgHA/cm3) 385.40 ± 12.07 450.90 ± 14.95CC 435.20 ± 18.31CC
pMOI(mm4) 6.619 ± 0.352 7.026 ± 0.494 6.892 ± 0.355
C.Th (mm) 0.1674 ± 0.0045 0.1773 ± 0.0051 0.1836 ± 0.0058
C.Sp (%) 0.2743 ± 0.0086 0.2391 ± 0.0071CC 0.2578 ± 0.0106
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
BV/TV, bone volume/total volume ratio; Tb.Th, Trabecular Thickness; Tb.Sp, Trabecular Separation; Tb.N, Trabecular Number; C.BMD Cortical Bone
Mineral Density, pMOI, polar Moment of Inertia, C.Th, Cortical Thickness, C.Sp, Cortical Porosity. Statistical significance was defined as p < 0.05
CC significantly different vs the CC group.
doi:10.1371/journal.pone.0154120.t008
Fig 5. Representative micro CT images of trabecular bone in the LV4 of offspring at adolescence. CC, Control group; Ca, Calcium-fortified group; Pre,
Prebiotic oligofructose-enriched inulin supplemented group.
doi:10.1371/journal.pone.0154120.g005
Mother’s Prebiotic Intake and Maternal and Offspring Bone
PLOSONE | DOI:10.1371/journal.pone.0154120 April 26, 2016 13 / 22
prebiotic oligofructose-enriched inulin supplementation produced an increase in C.BMD
(13%) (p = 0.032 vs CC group) and in cortical thickness (9%), with a parallel reduction in corti-
cal porosity (6%). Maternal Ca fortification also produced a significant increment in C.BMD
(17%) (p = 0.006 vs CC group), with a significant decrease in the cortical porosity (13%)
(p = 0.011 vs CC group), and a positive, but non-significant, increase of the cortical thickness
(6%).
At the end of adolescence, higher concentrations of serum ALP was found in the Ca group
with respect to the CC (p = 0.020) and Pre (p = 0.005) groups. Despite no significant differ-
ences were observed with respect to the CC group, a slight increase was also found in the bone
formation marker, i.e. osteocalcin, and a decrease in bone resorption marker, i.e. PTH, for both
Ca and Pre groups (Table 9).
Discussion
This study evaluated how maternal dietary intake of prebiotic oligofructose-enriched inulin
supplementation or Ca fortification may exert a protective effect on maternal bone loss associ-
ated to gestation and lactation and may also affect the peak bone mass accretion and bone qual-
ity of the offspring during their development and growing periods.
Maternal skeleton plays a fundamental role in the offspring bone development, providing
the calcium required for foetal development, principally during the third trimester of gestation,
at delivery and for milk production during lactation. Thus, the maternal Ca storage is depleted
over the course of pregnancy as the foetus accumulates 25 to 30g of Ca and during the nursing
period approximately 210mg of Ca per day is transferred for maternal milk production [20,
44, 45].
In the current study performed in rats, results showed that a non-deficient maternal diet
supplemented with prebiotic oligofructose-enriched inulin is able to prevent maternal skeleton
from the transient osteopenia associated to pregnancy and lactation while Ca fortification in
normal conditions did not exert any positive effect. Furthermore, a positive influence on the
offspring bones during the very early stages of life was exerted by both ingredients.
Ca is an essential nutrient for pregnancy and lactation. Taking into account that most preg-
nant and lactating women do not consume the recommended quantity of Ca (1000-1200mg/
day), supplementation is highly recommended to women in these periods. Thus, maternal sup-
plementation with Ca has shown to have maternal and foetal skeletal benefits[46]; however it
Table 9. Bone biomarkers in serum and 12h-acidified urine from offspring at adolescence.
CC group Ca group Pre group
(n = 8) (n = 8) (n = 8)
Bone formation biomarkers
Osteocalcin (mg/mol creatinine) 8404 ± 398 9698 ± 593 9323 ± 815
Alkaline phosphatase (U/mmol creatinine) 1475 ± 139 1962 ± 136CC 1311 ± 139Ca
Bone resorption biomarkers
DPD (μmol/mol creatinine) 198.8 ± 16.5 210.2 ± 28.7 242.0 ± 19.8
PTH (μg/mol creatinine) 1313 ± 200 1019 ± 131 1107 ± 109
Values are expressed as mean ± S.E.M. CC, Control group; Ca, Calcium fortified group; Pre, Prebiotic oligofructose-enriched inulin supplemented group;
Osteocalcin, Alkaline phosphatase and PTH (Parathyroid hormone) were measure in serum. DPD (Deoxypyridinoline) was measured in 12h-acidified
urine. Statistical significance was defined as p < 0.05.
CC significantly different vs the CC group
Casignificantly different vs the Ca group.
doi:10.1371/journal.pone.0154120.t009
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has also been related with other maternal health outcomes such as reduction of maternal risk
of pregnancy-hypertension, preeclampsia and other complications [47]. It must be considered
that most of the epidemiological studies have been done over deficient Ca population and,
therefore, a supplementation with this mineral could mean an overall positive increase on bone
health [20, 48]. However, not all human interventions have shown a positive effect of Ca sup-
plementation during gestation and lactation on maternal bone health preservation, even in
populations that consume very low Ca intakes [7]. Thus, in a recent publication, Jarjou et al.
[49] have found that Ca supplementation of pregnant Gambia women with low Ca intake
resulted in lower maternal bone mineral content during lactation.
In the present study, we found that dams from the Ca group showed the lowest BMD and
BMC when compared with the CC and Pre groups. Moreover this group showed the most dete-
riorated micro-structure, denoting a greater de-calcification during the gestation and lactating
periods. This means that, in our experimental conditions, no protection was obtained by Ca
fortification on maternal bone health during these periods. In the same way, Shackelford et al.
[50], in a study with well-nourished pregnant rats, observed a negative interaction between a
Ca fortified diet during pregnancy and the minerals Fe, Zn, Mg and P levels on different tissues.
Therefore, these results suggest that a unique supplementation with Ca during pregnancy and
lactation could not be enough as it could generate an impairment on the metabolism of other
essential minerals that are important for maternal health and for child development. In fact,
some researchers have suggested that it may not just be Ca which promotes bone health but
the synergistic effect of all of the nutrients in Ca rich foods [46, 51, 52].
New-born skeletal mineralization reflected the same effects of Ca fortification found in
maternal bone. At delivery, the trabecular parameters in the Ca group indicated that the off-
spring had less mineralized spongy bones than the CC group. This finding could support that a
maternal Ca-fortified diet in non-deficient conditions might have a negative effect on minerali-
zation of the foetal skeleton by altering the absorption and metabolism of other key minerals
such as Mg or P. Our data agrees with previous works reporting that high maternal Ca intake
during pregnancy negatively affects foetus development. In the study of Schakelford et al. [50],
a negative interaction was also observed between the Ca fortified diet during pregnancy and
the foetal mineral tissue levels. In this study, foetuses from dams, fed with a Ca enriched diet,
showed a decrease in the whole-body content Fe, Cu, P and Mg. Other studies have also
showed that a high Ca supplementation in pregnant females can result in a negative effect on
foetal bone mineral content [53, 54]. In contrast, an inadequate maternal store or intake of
minerals could have adverse effects on the foetus, resulting in stillbirth, intrauterine growth
retardation, and abnormal organ development [55].
At weaning, the Ca group offspring showed an improvement in the architecture of cancel-
lous bone at lumbar vertebrae in comparison to the CC group, although it was not related to
changes in the whole body BMD and BMC. This positive effect contrasts with the lower miner-
alization found at birth and confirms the significance of maternal Ca supplementation during
lactation, i.e., period in which the main Ca source for the pup is breast milk. In this sense,
expert committees recommended supplementation with Ca for premature infants fed with
human milk. Furthermore, Lapillone et al. [56] concluded that healthy preterm infants fed
with a Ca and P fortified formula, achieved a normal bone mass through an improvement in
bone mineralization.
The most important differences were observed at the end of adolescence. The Ca group ado-
lescent offspring presented a significant increase in the mineralization of the cancellous bone at
lumbar vertebra compared to the CC group, as shown by micro CT analysis. The increase
shown in trabecular thickness and the decrease in trabecular separation can be explained by an
increased modelling rate on the trabeculae surface that produces denser cancellous bones in
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the Ca group offspring. In fact, this group also showed an increment in bone formation bio-
markers, mainly in the alkaline phosphatase and a decrease, although no significant, in bone
resorption biomarkers (PTH). In general, the lumbar vertebrae showed an improvement not
only in cancellous bones but also in cortical bones. This improvement of the overall micro-
structure of bones implies that the vertebrae of the Ca group offspring may have a greater resis-
tance against bone breakage and collapse compared with the control group. These features
were not confirmed using densitometric analysis, which failed to show any positive effect on
BMD and BMC in the Ca group offspring compared with the CC group. Moreover, this was
not in accordance with previous studies where maternal Ca fortification increased the amount
of bone in offspring [54].
These results can be explained considering that our study was designed in non-deficient
conditions, i.e. the amounts of Ca provided by the standard AIN-93 rodent diet were enough
for covering adequate skeletal development. Similarly, other authors [3, 57, 58] reported that
maternal Ca and vitamin D fortification did not influence clinical outcomes related to the off-
spring size at birth as well as the BMD and BMC in the progeny of women without apparent
Ca and vitamin D deficiency. These results are in accordance with the concept of a threshold
for Ca intake expressed by Matkovic and Heaney [59], i.e. intakes of Ca above the recom-
mended level did not produce a further benefit.
On the other hand, prebiotic oligofructose-enriched inulin administration has showed to
exert a more protective effect of dam’s bones against the transient osteopenia associated to
pregnancy and lactation. Although no significant differences were found on BMD and BMC
when comparing with the CC group, slightly higher values were obtained for all the analyzed
bones. Taking into account that the cortical and the trabecular bone are included in the mea-
surements of BMD and BMC, differences between groups could be dissipated by the effect of
cortical bone that was less de-mineralized than the trabecular one. In fact, in humans, it is the
trabecular bone the most affected during lactation, having a 3–10% decrease in trabecular
BMC in women during 2 to 6 months of breastfeeding [60]. Similarly, Zeni et al.[61] have
found that the contribution of the dam’s skeleton to the lactation period was greater in the
areas with the highest trabecular composition. In this study, the proximal tibia of dams at
weaning was the bone most affected by the de-mineralization during lactation, with a decrease
in the BMD of 20% when compared to the non-pregnant control, while non-significant losses
were found in the areas of cortical bone, such as distal and middle tibia.
Accordingly, our results showed that it is at microstructure level and in the cancellous bone,
mainly of the tibia, where greater differences were found. The Pre group exhibited significant
greater trabecular thickness, BV/TV and Conn.D and also a significantly lower bone surface-
bone volume ratio than CC group denoting a higher protection, as trabeculae were lower de-
calcified. In the same way, the cancellous bone in this group had lower trabecular space, greater
trabecular number and significantly greater connectivity density than the Ca group denoting
that dams from the Pre group presented higher bone strength and stiffness. In fact, bone
strength depends not only on the quantity of bone tissue, evaluated by BMD using DEXA, but
also on the quality, which is characterized by the three-dimensional organization of the trabec-
ulae that is the microarchitecture[62].
Hence, prebiotic oligofructose-enriched inulin supplementation of the maternal diet during
pregnancy and lactation achieved to protect maternal bone against loss produced by the mater-
nal skeletal response to the demand of Ca necessary for foetal development. Although epidemi-
ological studies observed no effect between bone mass loss during lactation and incidence of
osteoporosis after menopause, it has been suggested that maternal BMD recovery after mater-
nity fails to reach the pre-pregnancy BMD level [20], and, therefore, it is conceivable that a pre-
vention of the osteopenia associated to lactation may exert a beneficial effect delaying and even
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decreasing the risk of osteoporosis later in life. Furthermore, it should also be taken into
account the fact that the age at last pregnancy, that occurs increasingly later, approached the
post-lactational recovery period to the perimenopause time, generating a situation in which the
maternal bone has not been totally recovered between both periods. Therefore, a lower loss of
bone during gestation and lactation could mean a greater protection against the osteoporosis
associated to menopause.
In the same way, our results showed a beneficial effect of nutritional intervention in the
mother during gestation and lactation over the offspring bone accrual. Prebiotic oligofructose-
enriched inulin supplementation in the maternal diet did not show any outstanding effect on the
bonemineralization or architecture in the offspring at delivery or at weaning. In contrast, this sup-
plementation produced a significant increase in BMD and BMC in the lumbar vertebrae of ado-
lescent offspring. The association between maternal prebiotic oligofructose-enriched inulin
consumption and higher BMD/BMC in infants’ spines may be partially attributed to the increased
mineral absorption from the maternal intestine, which could enhance the bio-availability and con-
centration of minerals in the placenta and breast milk. This increase might have a beneficial effect
improving the ossification process in the foetus and the new-born but also for maternal bone
against loss produced during gestation and lactation [63, 64]. Previous studies [15, 57] in healthy
gestating women, observed an association between maternal mineral intake during the third tri-
mester of pregnancy, and bone mass in their offspring at the age of 9 and 16. Both studies showed
a positive relationship between mother Mg intakes, and the lumbar spine BMD in the infants.
However, no such relationship was observed for maternal Ca intakes neither for the mother nor
for the offspring [65]. In addition, bone health effects of inulin/scFOS are shown to be mediated
by enhancing not only the intestinal absorption of Ca but also the absorption of other minerals
with bone-sparing effects, such as Mg and P [66].
Moreover, prebiotic oligofructose-enriched inulin supplemented diet during gestation and
lactation produces an increment on the structural features of the vertebra spongy bone. Com-
pared to control pups, the offspring from the Pre group showed the same trabecular number
but increased trabecular thickness (13%) and BV/TV (11%) that resulted in a denser bone, as
shown by DEXA measurement (BMD). The Pre group offspring also showed a significantly
higher C.BMD together with a greater cortical thickness in comparison to the CC group at the
end of the adolescence. This denotes a greater periosteal apposition and probably a reduced
endocortical resorption, thereby improving bone strength in the vertebrae. Cortical porosity
was also reduced in this group (-6%) with respect to the CC group indicating a positive or well-
balanced bone remodelling within each bone basic multicellular unit (BMU) that improved the
toughness of the vertebra cortex. Furthermore, the Pre group showed a higher bone formation/
bone resorption ratio (osteocalcin/PTH) with respect to CC group (8.42 vs 6.40), indicating an
increase in the modelling rate that is reflected at the microstructure level. Altogether, these
characteristics denoted a higher peak bone mass in the Pre group offspring, mainly promoted
by the maternal prebiotic consumption during offspring early stages of life.
Another possible mechanism of action of prebiotics on the protection of the maternal skele-
ton and on the improved bone quality of the offspring would be through the production of
short chain fatty acids (SCFA), such as butyrate, propionate, and acetate acids, by bacterial fer-
mentation in the intestinal lumen. These acids have shown to influence bone health by differ-
ent mechanisms. On the one hand, SCFA decrease the pH in the cecum, as is showed for the
Pre group, dissolving insoluble Ca and Mg salts and accelerating their passive diffusion and
absorption together with SCFA [26, 33, 67, 68]. On the other, SCFA have long term effects on
skeletal development possibly involving the differentiation of bone marrow mesenchymal stem
cells into osteoblasts [69] and stimulation of mineralized nodule formation[67, 70].
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Nevertheless, further experiments are needed to explore the mechanisms of action of the pro-
gramming effect of prebiotics.
Conclusion
In conclusion, this study demonstrates for the first time that prebiotic oligofructose-enriched
inulin supplementation during second half of gestation and lactation in rats exerted a protec-
tion on the trabecular structure of maternal bone against loss that occurs during pregnancy
and lactating periods, especially in the tibia. This positive effect may lead to a greater protection
against the bone loss that occurs later in life, when bones become thinner, resulting in a loss of
strength to cracks and/or collapses. Furthermore, maternal prebiotic oligofructose-enriched
inulin supplementation and Ca fortification produce a better structural base not only at spon-
giosa but also at the cortical vertebra of offspring bones, producing an increase in the offspring
peak bone mass and, therefore, could help delaying the bone loss produced in adulthood and
the risk of developing osteoporosis. Thus, based on our study results, prebiotic oligofructose-
enriched inulin supplementation in non-deficient nutritional conditions may be considered as
a plausible nutritional option for pregnant and lactating women rather than Ca supplementa-
tion, for maximizing the peak of bone mass in the offspring from the growing period till adoles-
cence, and for protection of the maternal bone mass during gestation and lactation as a
strategy to increase bone strength and to prevent bone fragility after menopause.
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